Publications

Publications for Aloke Finn, MD.

1.   Qiu C, DeYoung MB, Finn AV, Dichek DA.  Cationic Liposomes Enhance Adenovirus Entry Via a Pathway Independent of the Fiber Receptor and Alpha(v) integrins.  Human Gene Therapy 1998;9(4):507-520.  PMID: 9525312

2.   Camargo FD, Huey-Louie DA, Finn AV, Sassani AB, Cozen AE, Moriwaki H, Schneider DB, Agah R, Dichek DA.  Germline Incorporation of a Replication-Defective Adenoviral Vector in Mice Does Not Alter Immune Responses to Adenoviral Vectors.  Mol Therapy 2000;2(5):496-504.  PMID: 11082323

3.   Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV, Virmani R. The Thin-cap Fibroatheroma: a Type of Vulnerable Plaque: the Major Precursor Lesion to Acute Coronary Syndromes.  Curr Opin Cardiol 2001;16(5):285-291.  PMID: 11584167

3.   Finn AV, Gold HK, Tang A, Weber DK, Wight TN, Clermont A, Virmani R, Kolodgie FD. A Novel Rat model of Carotid Artery Stenting for the Understanding of Restenosis in Metabolic Diseases. J Vasc Res 2002;39(5):414-25.  PMID: 12297704

4.  Kolodgie FD, Gold HK, Burke AP, Fowler DR,  Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque Hemorrhage and Progression of Coronary Atheroma. N Engl J Med 2003;349(24):2316-25.  PMID: 14668457

5.   Rubenstein MH, Finn AV, Leinbach RC, Hollenbach S, Aretz HT, Virmani R, Gold HK. Short term Intravenous Eptifibatide Infusion Combined With Reduced Dose Recombinant Tissue Plasminogen Activator Inhibits Platelet Recruitment at Sites of Coronary Artery Injury. J Am Coll Cardiol 2004;43(2):287-94.  PMID: 14736451

6.   Kolodgie FD, Virmani R, Burke AP, Farb A, Weber DK, Kutys R, Finn AV, Gold HK.  Pathologic assessment of the vulnerable human coronary plaque.  Heart 2004;90(12):1385-91.  PMID: 15547008.

7.   Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents. Circulation 2005;112(2):270-8.  PMID: 15998681

8.   Finn AV, Palacios IF, Kastrati A, Gold HK. Drug Eluting Stents For Diabetes Mellitus: A Rush to Judgement?  J Am Coll Cardiol 2005;45(4):479-483.

9.   Narula, J, Finn, AV, DeMaria AN. Picking Plaques that Pop.  JACC 2005;45(12):1930-PMID: 15708689.

10.  Woodward RN, Finn AV, Dichek DA. Identification of Intracellular Pathways Through which TGF- beta1 Upregulates PAI-1 Expression in Endothelial cells. Atherosclerosis 2006;186(1):92-100.  PMID: 16139837

11.  Finn AV, Nakazawa G,  Joner M, Virmani R. Everolimus Eluting Stents:  Beyond Targeting Restenosis.  EuroIntervention 2006;2(7):277-279.  PMID: 160375678.

12.  Joner M*, Finn AV*, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk.  J Am Coll Cardiol 2006;48(1):193-202.  PMID: 16814667 (* equal contribution)

13.  Joner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie FD, Virmani R. Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting Transforming Growth Factor-β and MCP-1.  Arterioscler Thromb Vasc Biol 2007;27(1):182-9.  PMID: 17068283

14.  Finn AV, Joner M, Nakazawak G, Klodgie FD, Newell J, John MC, Gold HK, Virmani R.  Pathologic Correlates of Late Drug Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization. Circulation 2007;115(18):2435-41.  PMID: 17438147

15.  Sheth T, Dodd J, Hoffmann U, Abbara S, Finn AV, Gold, HK, Brady TJ, Cury RC. Coronary Stent Assessability by 64 Slice Multi-Detector Computed Tomography. Catheterization and Cardiovascular Interventions 2007;69(7):933-8.  PMID: 17421013

16.  Ribichini F, Joner M, Ferrero V, Finn AV, Crimins J, Nakazawa G, Acampado E, Kolodgie FD, Corrado V, Virmani R. Effects of Oral Prednisone After Stenting in a Rabbit Model of Established Atherosclerosis. J Am Coll Cardiol 2007;50(2):176-85.  PMID: 17616304

17.  Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW, Virmani R, Muller, JE.  Frequency and Distribution of Thin-Cap Fibroatheroma and Ruptured Plaques in Human Coronary Arteries – A Pathologic Study. J Am Coll Cardiol 2007;50(10):940-9.  PMID: 17765120

18.  Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing.  Arterioscler Thromb Vasc Biol 2007;27:1500-1510. PMID: 17510464

19.  Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, Virmani R. Elimination of Neoangiogenesis for Plaque Stabilization: Is There a Role for Local Drug Therapy? J Am Coll Cardiol  2007;49(21):2093-101. PMID: 17531658

20.  Nakazawa G, Finn AV, Virmani R. Virtual Histology: Does It Add Anything?? Heart 2007;93(8): 897-8. PMID: 17639103

21.   Finn AV, Gold HK.  Total Erythrocyte Membrane Cholesterol: A Marker of Plaque Instability? Nature Clinical Practice Cardiovascular Medicine 2007;4(12):646-7.  PMID: 17768403

22.  Finn AV, Nakazawa G, Narula J, Virmani R.  Culprit Plaque in Myocardial Infarction Going Beyond Angiography.  J Am Coll Cardiol 2007;50(23):2204-6. PMID: 1806106614.

23.  Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J.  Atherosclerotic Plaque Progression and Vulnerability to Rupture Angiogenesis as a Source of Intraplaque Hemorrhage.  Arterioscler Thromb Vasc Biol 2005;25(10):2054-2061. (top 50 cited paper in ATVB)

24.  Nakazawa G, Finn AV, Virmani R.  Vascular Pathology of Drug Eluting Stents.  Herz 2007;32(4):274-80.  PMID: 17607533

25.  Finn AV, Nakazawa G, Kolodgie FD, Virmani R.  Controversies Surrounding the Use of Drug Eluting Stents.  Am Heart Hosp J  2007;5(3):141-5.  PMID: 17673854

26.  Jain RK, Finn AV, Kolodgie FD, Gold HK, Virmani R. Antiangiogenic Therapy for       Normalization of Atherosclerotic Plaque Vasculature: A Potential Strategy for Plaque Stabilization. Nature Clinical Practice Cardiovascular Medicine 2007;4(9):491-502.  PMID: 17712362

27.  Nakazawa G, Finn AV, John M,, Kolodgie FD, Virmani R. On the Significance of Preclinical Evaluation of Evaluation of Sirolimus, Paclitaxel, and Zotarolimus-Eluting Stents.  Am J of Cardiology 2007;100(8B):36M-44M.  PMID: 1795083122.

28.  Joner, M; Nakazawa, G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Gold HK, Kolodgie FD, Virmani R. Endothelial Cell Recovery Between Comparator  Polymer-Based Drug-Eluting Stents.  J Am Coll Cardiol 2008;52(5):333-42. PMID: 18652940

29.  Joner M, Morimoto K, Kasukawa H, Steigerwald K, Nakazawa G, John MC, Finn AV, Acampado E, Kolodgie FD, Gold HK, Virmani R. Site Specific Targeting of Nanoparticle Prednisolone Reduces in-Stent Restenosis in a Rabbit Model of Established Atheroma.  Arterioscler Thromb Vasc Biol 2008;28(11):1960-6. PMID: 18688017.

30.  Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R.  Human Pathology of Drug Eluting Stents Implantation For Acute Myocardial Infarction: the Importance of Plaque Morphology in Delayed Healing and Risk for Late Stent Thrombosis.  Circulation 2008;118(11):1138-45. PMID: 18725485.

31.  Jaffer FA, Vinegoni C, John MC, Aikawa E, Gold HK, Finn AV, Ntziachristos V, Libby P, Weissleder R.  Real Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis.  Circ 2008;118(18):1802-9. PMID: 18852366.

32.  John MC, Wessely R, Kastrati A, Schomig A, Joner M, Uchihashi M, Crimins J, Lajoie C, Kolodgie FD, Gold HK, Virmani R, Finn AV.  Differential Healing Response in Polymer and Non-Polymer Based Sirolimus Eluting Stents.  J Am Coll Cardiol: Cardiovascular Interventions  2008;1(5):535-544.  PMID: 19463356.

33.  Finn AV, Nakazawa G, Ladich E, Kolodgie FD, Virmani R. Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?  JACC Cardiovasc Imaging 2008;1(4):485-8.  PMID: 1935647119.

34.  Finn AV, Oh JS, Hendricks M, Daher M, Cagliero E, Byrne RM, Nadelson J, Crimins J, Kastrati A,  Schomig   A, Bruskina O, Palacios IF, John MC, Gold HK. Predictive Factors for In-Stent Late Loss and Coronary Lesion Progression in Patients with Type 2 Diabetes Mellitus Randomized to Rosiglitazone or Placebo.  Am H Journal 2009;157(2):383.e1-8. PMID: 19185649.

35.  Finn AV, John MC, Nakazawa G, Polavarapu R, Karmali V, Xu X, Cheng Q, Davis T, Raghunathan, Acampado E, Ezell T, Lajoie S, Eppihimer M, Kolodgie FD, Virmani R, Gold HK.  Circulation Research 2009;105(10):1003-12.  PMID: 19797172

36.  Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Kolodgie FD, Virmani R. Incidence and Predictors of Drug Eluting Stent Fracture in Human Coronary Artery-A Pathologic Analysis. J Am Coll Cardiol 2009;54(21):1924-31.  PMID: 19909872

37.  Finn AV, Nakazawa G, Kolodgie FD, Virmani R. Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?  JACC Cardiovasc Interv 2009;2(4):300-2.  PMID: 19463440

38.  Vorpahl M, Finn AV, Nakano M, Virmani R.  Do We Really Understand Pimecrolimus? JACC Cardiovasc Interv 2009;2(10):1025-7.  PMID: 19850265

39.  Finn AV, Nakazawa G, Kolodgie FD, Virmani R. Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety? Eur Heart J 2009 ;30(15):1828-30.  PMID: 19515688

40.  Finn AV, Kramer MC, Vorpahl M, Kolodgie FD, Virmani R. Pharmacotherapy of coronary atherosclerosis.  Expert Opin Pharmacother 2009;10(10):1587-603. PMID: 19527187

41.  Vorpahl M, Virmani R, Ladich E, Finn AV. Vascular remodeling after coronary stent implantation.  Minerva Cardioangiol 2009;57(5):621-8. PMID: 19838152

42.  Nakazawa G, Yazdani SK, Finn AV, Vorpahl M, Kolodgie FD, Virmani R. Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. J Am Coll Cardiol 2010;55(16):1679-87. PMID: 20394871

43.  Finn AV, Jain RK. Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization?  JACC Cardiovasc Imaging 2010;3(1):41-4.  PMID: 20129529

44. Finn AV, Chandrashekhar Y, Narula J. Seeking Alternatives to Hard End Points: Is Imaging the Best APPROACH?  Circulation. 2010;121(10):1165-8. PMID: 20194886

44.  Finn AV, Kolodgie FD, Virmani R. Correlation Between Carotid Intimal/Medial Thickness and Atherosclerosis. A Point of View From Pathology.  Arterioscler Thromb Vasc Biol 2010;30(2):177-81.  PMID: 1967983336.

45.  Finn AV, Vorpahl M, Ladich E, Virmani R.  Future Directions in Stenting.  Expert Rev Cardiovasc Ther 2010;8(1):1-6.  PMID: 20014929

46.  Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30(7):1282-92.  PMID: 20554950.

47.    Finn AV, Kolodgie FD, Nakano M, Virmani R. The differences between neovascularization of chronic total occlusion and intraplaque angiogenesis.  JACC Cardiovasc Imaging 2010;3(8):806-10.  PMID: 20705259

48.  Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First Generation Sirolimus- and Paclitaxel- Eluting Stents. J Am Coll Cardiol 2011;57(4):390-8.  PMID: 21251578

49.   Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R.  The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.  J Am Coll Cardiol 2011;57(11):1314-22.  PMID: 21376502

50.   Cutlip DE, Nakazawa G, Krucoff MW, Vorpahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R.  Autopsy validation study of the academic research consortium stent thrombosis definition.  JACC Cardiovasc Interv 2011;4(5):554-9.  PMID: 21596329

51.   Tawakol A, Finn AV. Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride. JACC Cardiovasc Imaging 2011;4(10):1119-22.  PMID: 21999872.

52.   Nakano M, Otsuka F, Finn AV, Virmani R. Microvascular obstruction is caused by atherothrombosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention.  Circ Cardiovasc Imaging 2011;4(6):597-600. PMID: 22086941.

53.   Finn AV, Chandrashekhar Y, Narula J. IVUS and OCT: either or survivor?  JACC Cardiovasc Imaging 2011;4(9):1047-9. PMID: 21920345

54.  Marwick TH, Chandrashekhar Y, Achenbach S, Dilsizian V, Fayad ZA, Finn AV, Hundley WG, Kern MJ, Kramer CM, Sengupta PP, Shaw LJ, Zoghbi WA, Narula J.  Bibliographic metrics at JACC: cardiovascular imaging an opportunity for audit and reflection.  JACC Cardiovasc Imaging 2011;4(9):1050-1. PMID: 21920346.

55.  Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, Narula J, Kolodgie FD, Virmani R. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol 2012;59(2):166-77.  PMID: 2215477.

56.  Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, Rostad B, Pachura K, Adams L, Elliott J,Taylor WR, Narula J, Kolodgie F, Virmani R, Hong CC, Finn AV. Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis. Arterioscler Thromb Vasc Biol 2012:32(2):299-307.  PMID: 22095982.

57.   Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, Ladich ER, Kolodgie FD, Virmani R.  Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging.  JACC Cardiovasc Imaging 2012;5(1):71-82.  PMID: 22239896

58.   Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Timmins LH, Binongo JN, Golub LJ,Corban MT, Finn AV, Oshinski JN, Quyyumi AA, Giddens DP, Samady H. Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease. J Am Heart Assoc. 2012 Aug;1(4):e002543. Epub 2012 Aug 24. PMID:  23130168

59.   Yazdani SK, Farb A, Nakano M, Vorpahl M, Ladich E, Finn AV, Kolodgie FD, Virmani R. Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions JACC Cardiovasc Interv. 2012 Jun;5(6):666-74.  PMID: 22721663

60.  Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol. 2012 May 22. doi: 10.1038/nrcardio.2012.64. [Epub ahead of print] PubMed PMID: 22614618.

61.    Boden WE, Finn AV, Patel D, Frank Peacock W, Thadani U, Zimmerman FH. Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. Clin Cardiol. 2012 May;35(5):263-71. doi: 10.1002/clc.21993. Epub 2012 Apr 23. PubMed PMID: 22528319.

63.    Rowley JW, Finn AV, French PA, Jennings LK, Bluestein D, Gross PL, Freedman JE, Steinhubl SR, Zimmerman GA, Becker RC, Dauerman HL, Smyth SS; 2011 Platelet Colloquium Participants. Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. Circ Cardiovasc Interv. 2012 Apr;5(2):296-304. PubMed PMID: 22511738.

64.   Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcombe R, Malik S, Fuster V, Finn AV.  Histomorphological Characterization of High-Risk Atherosclerotic Plaques with Emphasis on Luminal Stenosis and Amenability to Invasive and Noninvasive Clinical Imaging.  J Am Coll Cardiol 2013 Mar12;61(10):1041-51. doi: 10.1016/j.jacc.2012.10.054.  PMID: 23473409.

65.   Finn AV and Otsuka F.  Late Bare Metal Stent Thrombosis: A Culprit in Very Late Stent Thrombosis.  Circ Cardiovasc Interverv 2012:5(1):6-9. PMID: 22338000

66.    Finn AV, Chandrashekhar Y, Narula J.  Vulnerable Plaques: From PROSPECT to ProspectsJACC Cardiovasc Imaging 2012;5(3):334-6.  PMID: 22421182.

67. Yazdani SK, Otsuka F, Nakano M, Finn AV, Virmani R. Do animal models of vein graft atherosclerosis predict outcomes in man? Atherosclerosis. 2012 May 12.  [Epub ahead of print] PubMed PMID: 22658552.

68. Finn AV, Narula J. Intraplaque hemorrhage: most dangerous is the wound that bleedeth inwardly…. JACC Cardiovasc Imaging. 2012 Aug;5(8):856-8. PMID: 22898003. 69. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013 Mar;34(10):719-28. PubMed PMID: 23242196.51.

70.   Habib A, Karmali V, Polavarapu R, Nakano M, Yazdani S, Otsuka F, Pachura K, Davis T, Kolodgie FD, Virmani R, Finn AV.  Metformin Impairs Vascular Endothelial Recovery After Stent Placement In the Setting of Locally Eluted mTOR inhibitors via S6K Dependent Inhibition of Cell Proliferation.  J Am Coll Cardiol 2013 Mar 5;61(9):971-80. doi: 10.1016/j.jacc.2012.12.018.  PMID: 23449430

71.   Habib A, Karmali V, Polavarapu R, Akahori H, Pachura K, Finn AV.  Metformin Impairs Endothelialization After Placement of Newer Generation Drug Eluting StentsAtherosclerosis 2013 Aug; 229(2): 385-387.

72.   Habib, A., Karmali, V., Polavarapu, R., Akahori, H., Cheng, Q., Pachura, K., Kolodgie, F.D., Finn, A.V.  Sirolimus-FKBP12/12.6 impairs endothelial barrier function through PKC activation and disruption of the VE cadherin-p120 interaction.  Arterioscler Thromb Vasc Biol, Epub Oct;33(10):2425-31Epub 2013 Jul 25. PMID: 23887639 PMCID in process.

73.   Nakano M, Otsuka F, Yahagi K, Sakakura K, Kutys R, Ladich ER, Finn AV, Kolodgie FD, Virmani R. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics.  Eur Heart J. 2013 Oct 14. [Epub ahead of print].

74.   Sakakura K, Nakano M, Otsuka F, Yahagi K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R.  Comparison of pathology of chronic total occlusion with and without coronary artery bypass graft. Eur Heart J. 2013 Oct 14. [Epub ahead of print] PubMed PMID: 24126875.

75.   Halkos ME, Walker PF, Vassiliades TA, Douglas JS, Devireddy C, Guyton RA, Finn AV, Rab ST, Puskas JD, Liberman HA. Clinical and Angiographic Results After Hybrid Coronary Revascularization. Ann Thorac Surg. 2013 Oct 17. doi:pii: S0003-4975(13)01911-5. 10.1016/j.athoracsur.2013.08.041. [Epub ahead of print] PubMed PMID: 24140212.

76.   Otsuka F, Vorpahl M, Nakano M, Foerst JR, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R. Pathology of Second-Generation Everolimus-Eluting Stents versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans. Circulation. 2013 Oct 25. [Epub ahead of print] PubMed PMID: 24163064.

77.   Halkos ME, Liberman HA, Devireddy C, Walker P, Finn AV, Jaber W, Guyton RA, Puskas JD. Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2013 Oct 27. doi:pii: S0022-5223(13)01082-9. 10.1016/j.jtcvs.2013.09.010. [Epub ahead of print] PubMed PMID: 24172691.

78.  Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari DE, Kereiakes DJ, Waksman R, Mauri L, Meredith IT, Finn AV, Kim HS, Kubica J, Suryapranata H, Aprami TM, Di Pasquale G, von Birgelen C, Kedhi E. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMJ. 2013 Nov 6;347:f6530. doi: 0.1136/bmj.f6530. PubMed PMID: 24196498; PubMed Central PMCID: PMC3819044.

79.   Campbell IC, Timmins LH, Giddens DP, Virmani R, Veneziani A, Rab ST, Samady H,McDaniel MC, Finn  AV, Taylor WR, Oshinski JN. Computational Fluid Dynamics Simulations of Hemodynamics in Plaque  Erosion. Cardiovasc Eng Technol. 2013 Dec;4(4). doi: 10.1007/s13239-013-0165-3. PubMed PMID: 24223678; PubMed Central PMCID: PMC3819207.

80.  Otsuka F, Finn AV, Virmani R. Do vulnerable and ruptured plaques hide in heavily calcified arteries? Atherosclerosis. 2013 Jul; 229(1): 34-37. [Epub ahead of print] PubMed PMID: 23375681.

81.   Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z,Virmani R, Fuster V, Bosca L, Narula J. 2-deoxy-2-[(18)F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis. Nat Med. 2014 Jan 12.  doi: 10.1038/nm.3437. [Epub ahead of print] PubMed PMID: 24412923.

82.   Nakano M, Yahagi K, Otsuka F, Sakakura K, Finn AV, Kutys R, Ladich E, Fowler DR, Joner M, Virmani  R.  J Am Coll Cardiol. 2014 Apr 12. doi: 10.1016/j.jacc.2014.02.607. [Epub ahead of print] PMID: 24768883.

83.   Anwer Habib, Karmali V, John MC, Polavarapu R, Nakazawa G, Pachura K, BS, Davis T, Kolodgie FD, Virmani R, Finn AV. Everolimus Eluting Stents Improves Vascular Response in a Diabetic Animal Model.  Circulation Cardiovascular Interventions. 2014 Jun 10. pii: CIRCINTERVENTIONS.113.001023. [Epub ahead of print] PMID: 24915972

84.  Habib A and Finn AV.  Evaluating the vascular response of bioabsorable polymer drug-eluting stents in atherosclerosis.  Coronary Artery Disease. 2014 May; 25(3): 190-1.  PubMed PMID: 24714211.

85.  Habib A, Finn AV.  The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis.  Frontiers in Pharmacology. 2014 Aug 27;5:195. PMID: 25221512.

86.   Finn AV.  Eosinophils: An Overlooked Player in Acute Myocardial Infarction?”  Coronary Artery Disease 2015. Mar;26(2):99-100.  PMID:25647369.

87.   Finn AV.  Illuminating Culprit Plaque Histology by OCT: Shedding New Light on Old Insights.  JACC Cardiovasc Interv.  2015 Aug 17;8(9):1177-9.  PMID: 26210807.

88.   Kolodgie FD, Virmani R, Finn AV, Romero M.  Embolic Myocardial Infarction as Consequence of Atrial Fibrillation: A Prevailing Disease of the Future.  Circulation. 2015 Jul 28;132(4):223-6. PMID:26216083

89.   Yahagi K, Kolodgie F, Otsuka F, Finn AV, Davis H, Joner M, Virmani R.  Atherosclerosis: Comparison of Native Coronary Vein Graft, and In-Stent.  Nature Clinical Practice Cardiovascular Medicine.  2015 (In Press).

90.   Otsuka F, Kramer MC, Woudstra P, Yahagi K, Ladich E, Finn AV, De Winter RJ, Kolodgie FD, Wight TN, David HR, Joner M, Virmani R.  The Natural Progression of Atherosclerosis from Pathologic Intimal Thickening to Late Fibroatheroma in Human Coronary Arteries: A Pathology Study.  Atherosclerosis. 2015. Aug;241(2):772-82.  PMID: 26058741.

91.   Habib A, Polavarapu R, Karmali V, Guo L, Van Dam R, Cheng Q, Akahori H, Saeed O, Nakano M, Pachura K, Hong CC, Shin E, Kolodgie F, Virmani R, Finn AV.  Hepcidin-Ferroportin Axis Control Toll-Like Receptor 4 Dependent Macrophage Inflammatory Responses in Human Atherosclerotic Plaques.  Atherosclerosis. 2015.  Aug; 241(2):692-700.  PMID: 26125411.

92.  Habib A, Finn AV.  Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration.  Pharmacol Res. 2015 Mar;93:22-7.

93.   Akahori H, Karmali V, Polavarapu R, Lyle A, Weiss D, Shin E, Husain A, Naqvi N, Van Dam R, Habib A, Choi CU, King AL, Pachua K, Taylor WR, Lefer D, Finn AV.  CD163 TWEAK Interaction Regulates Tissue Regeneration After Ischemic Injury.  Nat Comm. 2015. Aug 5;6:7792.  PMID:26242746.

94.  Finn AV, Virmani R.  The Clinical Challenge of Disappearing Stents.  The Lancet.  (In Press).